Vuk Jeremic
Known title: DirectorCIK: 0001953202
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
ONCO Included in 12 Health Care Stocks Moving Intraday. On Monday and Tuesday, ONCO was listed among 12 health‑care stocks that saw notable intraday price swings. The moves were accompanied by higher than usual trading volume, indicating increased interest. The stock’s RSI sits near 47, suggesting it is neither overbought nor oversold. These developments may influence short‑term trading activity for ONCO.
Transaction History
| PUSA | ▲ Buy | Grant | 50,000 | $50 | 1/29/2026 | View on chart |
| ONCO | ▲ Buy | Grant | 6,360 | $0 | 5/31/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Powerus merger with Aureus Greenway closes, stock trades as PUSA
Powerus has officially completed its merger with Aureus Greenway Holdings, transitioning to a public company listed on the Nasdaq under the ticker PUSA. This corporate action marks the end of the pending merger process and establishes the new trading identity for the entity. The stock currently trades within a 52-week range of $2.60 to $6.57, with one analyst maintaining a target price of $7.50.
Powerus merger with Aureus Greenway closes, stock trades as PUSA. Powerus has officially completed its merger with Aureus Greenway Holdings, transitioning to a public company listed on the Nasdaq under the ticker PUSA. This corporate action marks the end of the pending merger process and establishes the new trading identity for the entity. The stock currently trades within a 52-week range of $2.60 to $6.57, with one analyst maintaining a target price of $7.50.